OC FY 2005 Priorities: MDUFMA, Bioterror, Closing Out Enforcement Actions
This article was originally published in The Gray Sheet
Executive Summary
Fiscal 2005 marks the inaugural year for the CDRH Office of Compliance's new inspection planning process, an initiative that reflects FDA's emphasis on risk-based regulation
You may also be interested in...
Senate Crafts Import Safety Bill, As Device Reps Prep For House Hearing
Sen. Ted Kennedy, D-Mass., is crafting a bill to strengthen FDA's oversight of products manufactured overseas, including devices
Senate Crafts Import Safety Bill, As Device Reps Prep For House Hearing
Sen. Ted Kennedy, D-Mass., is crafting a bill to strengthen FDA's oversight of products manufactured overseas, including devices
CDRH Compliance Office Seeks Inroads With FDA Office Of Regulatory Affairs
The top near-term contribution of the Office of Compliance to CDRH's postmarket reform effort will be trying to improve its working relationship with FDA's Office of Regulatory Affairs